COMP <GO>
PROF vs ANIK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Profound Medical Corp. (NASDAQ) VS. Anika Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: PROF 3
— ANIK 6
■ METRIC PARITY
LAST: $6.57 (+12.12%) • MKT CAP: $240.0M
options-implied-move
—
LAST: $20.95 (-3.85%) • MKT CAP: $280.4M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PROF VS. ANIK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PROF | ANIK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.80% | 56.60% | +14.20 | PROF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -10.20% | -24.80 | ANIK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -17.93% | 1.50% | -19.43 | ANIK | /fcf-yield <GO> |
| Operating Margin | -60.00% | -9.80% | -50.20 | ANIK | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -9.80% | -50.20 | ANIK | /net-margins <GO> |
| Revenue Growth (YoY) | 65.30% | -5.90% | +71.20 | PROF | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.97 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | ANIK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.4 | 51.8 | +4.60 | PROF | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $240.0M | $280.4M | -$40.4M | ANIK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PROF REV | ANIK REV | PROF GROSS % | ANIK GROSS % | PROF FCF | ANIK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $16.1M | $112.8M | 70.8% | 56.6% | -$38.4M | $4.4M |
| FY 2024 | $9.7M | $119.9M | 72.2% | 63.4% | -$23.5M | -$2.3M |
| FY 2023 | $5.9M | $120.8M | — | — | -$22.6M | -$1.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PROF // BETA —
ANIK // BETA —